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ABSTRACT
BACKGROUND: Attention-deﬁcit/hyperactivity disorder (ADHD) is associated with structural abnormalities in total
gray matter, basal ganglia, and cerebellum. Findings of structural abnormalities in frontal and temporal lobes,
amygdala, and insula are less consistent. Remarkably, the impact of comorbid oppositional deﬁant disorder (ODD)
(comorbidity rates up to 60%) on these neuroanatomical differences is scarcely studied, while ODD (in combination
with conduct disorder) has been associated with structural abnormalities of the frontal lobe, amygdala, and insula. The
aim of this study was to investigate the effect of comorbid ODD on cerebral volume and cortical thickness in ADHD.
METHODS: Three groups, 16 6 3.5 years of age (mean 6 SD; range 7–29 years), were studied on volumetric and
cortical thickness characteristics using structural magnetic resonance imaging (surface-based morphometry):
ADHD1ODD (n = 67), ADHD-only (n = 243), and control subjects (n = 233). Analyses included the moderators age,
gender, IQ, and scan site.
RESULTS: ADHD1ODD and ADHD-only showed volumetric reductions in total gray matter and (mainly) frontal brain
areas. Stepwise volumetric reductions (ADHD1ODD , ADHD-only , control subjects) were found for mainly frontal
regions, and ADHD1ODD was uniquely associated with reductions in several structures (e.g., the precuneus). In
general, ﬁndings remained signiﬁcant after accounting for ADHD symptom severity. There were no group
differences in cortical thickness. Exploratory voxelwise analyses showed no group differences.
CONCLUSIONS: ADHD1ODD and ADHD-only were associated with volumetric reductions in brain areas crucial
for attention, (working) memory, and decision-making. Volumetric reductions of frontal lobes were largest in the
ADHD1ODD group, possibly underlying observed larger impairments in neurocognitive functions. Previously
reported striatal abnormalities in ADHD may be caused by comorbid conduct disorder rather than ODD.
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Attention-deﬁcit/hyperactivity disorder (ADHD) is one of the
most common childhood psychiatric disorders and is deﬁned
by developmentally inappropriate levels of inattention, and/or
hyperactivity/impulsivity (1). Neuroanatomical ﬁndings most
consistently reported for ADHD are reduced total gray matter
volume and reduced volume of the basal ganglia and the cer-
ebellum. For the latter, cortical thickness abnormalities are also
associated with ADHD. In addition, volumetric reductions and
reduced cortical thickness of the frontal and temporal lobes
have been reported, although less consistently [for reviews, see
(2,3)]. Finally, some studies reported volumetric abnormalities
in the amygdala and insula to be related to ADHD, but the
ﬁndings are inconsistent, especially for the amygdala (4–9).
A potential explanation for the inconsistent neuroanatomical
ﬁndings may be the presence of comorbid disorders in the
studied ADHD samples, such as oppositional deﬁant disorder
(ODD). ODD is present in up to 60%of clinically referred children
with ADHD (10–12) and is deﬁned by a persistent pattern of
irritable and angry mood, vindictiveness, and developmentally
inappropriate, negativistic, deﬁant, and disobedient behavior
toward authority ﬁgures (1). Comparedwith individuals with only
ADHD or ODD, individuals with ADHD1ODD show an earlier
age of onset for both ADHD and ODD symptoms, exhibit more
physical aggression and delinquency, show more functional
impairments, such as poorer working memory, inhibition,
temporal processing, and emotion recognition, and have a
considerably worse prognosis (11,13,14).
Surprisingly, most studies on neuroanatomical correlates of
ADHD did not investigate or report on the presence of
comorbidities, such as ODD, resulting in relatively few studies
investigating ADHD-only samples. The few studies in ADHD-
only samples were less likely to ﬁnd volumetric abnormalities
in the frontal cortex than studies that included comorbid
individuals [for an overview, see (15)]. They also showed that
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accounting for the presence of comorbid ODD signiﬁcantly
inﬂuenced ﬁndings, with either larger abnormalities in in-
dividuals with ADHD1ODD (16) or more abnormalities asso-
ciated with ADHD after controlling for comorbid ODD (17). In
addition, studies assessing ADHD-only groups showed no
volumetric abnormalities in the amygdala (4,6,7), and abnor-
malities in the insula were accounted for by comorbid ODD (8).
For cortical thickness, an inﬂuential study showed a delay in
cortical development for individuals with ADHD, but of that
sample 35% of the individuals had a comorbid diagnosis of
ODD (3,18). Thus, previous ﬁndings may not purely reﬂect
neuroanatomical characteristics of ADHD but may be
confounded by comorbid ODD.
An alternative explanation for the inconsistent neuroana-
tomical ﬁndings for ADHD could be the age of included par-
ticipants. According to the maturational delay hypothesis (18),
individuals with ADHD show a maturational lag in brain
development compared with typically developing control (TDC)
subjects. According to this theory, the maturational lag is most
prominent in prefrontal regions and has been reported to
correspond with a 3-year delay, with TDC subjects attaining
their peak cortical thickness at 7.5 years of age and individuals
with ADHD at 10.5 years of age (18). In addition, it has been
reported that structural abnormalities in the basal ganglia
normalize with age (2,19). However, in contrast with the
maturational delay hypothesis, structural abnormalities in the
anterior cingulate cortex seem to persist into adulthood (2,20).
Hence, studying the impact of comorbid ODD and age is
pivotal to understanding the heterogeneity in ﬁndings.
So far, no studies on neuroanatomical correlates exclusively
focused on individuals with ODD-only or on ADHD1ODD.
Rather, studies included mixed samples of children with ADHD
with and without comorbid ODD, or included children with both
(comorbid) ODD and conduct disorder (CD) (a related disorder
forwhichODD is oftenaprecursor) (21). The studies that focused
on volumetric characteristics of individuals with ODD/CD with
and without comorbid ADHD consistently reported reduced
volumes of the amygdala, insula, and frontal lobe [for a review,
see (21)]. Furthermore, it hasbeen reported thatCD is associated
with volumetric abnormalities in frontal areas, while this asso-
ciation seemed relatively weak for ADHD-only (15). In terms of
cortical thickness, one study investigated an ODD/CD sample
and reported a decreased overall mean cortical thickness and
thinning of the cingulate, prefrontal, and insular cortices (22).
To summarize, while neuroanatomical abnormalities in
ADHD-only appear to be most strongly related to the frontal
regions, ADHD1ODD appears associated with abnormalities
in the frontal regions, amygdala, and insula. The overlap in
affected brain areas may explain inconsistencies in reported
abnormalities for frontal areas in ADHD, because these may be
driven (partly) by the presence of comorbid ODD or by a
combined effect of both disorders. So far, the literature does
not answer the question on whether previously reported
abnormalities in ADHD reﬂect neuroanatomical characteristics
of ADHD or rather of comorbid ODD. Therefore, a comparison
between individuals with ADHD1ODD and individuals with
ADHD-only would be highly informative in terms of speciﬁcity
of ﬁndings for ADHD. This may also clarify whether previously
reported structural abnormalities in the amygdala and insula
were driven by comorbid ODD.
The current study aimed to disentangle brain abnormalities
associated with ADHD versus ADHD1ODD by comparing
these diagnostic groups to TDC subjects across a broad age
range from childhood to late adolescence. We studied the
impact of age in order to test whether individuals with ADHD
showed a maturational delay in neuroanatomical development.
To meet these aims, neuroanatomical volumes and cortical
thickness were compared between a large sample of
individuals with ADHD without ODD (ADHD-only), individuals
with ADHD and ODD (ADHD1ODD), and TDC subjects. We
hypothesized that 1) abnormalities in the basal ganglia and
cerebellum would be strongly associated with ADHD and
therefore present in both diagnostic groups and that 2) abnor-
malities in the amygdala and the insula would be driven by
ODD rather than by ADHD and hence would be predominantly
present in the ADHD1ODD group rather than the ADHD-only
group. Furthermore, we speculated that 3) abnormalities in
the frontal lobes would be more pronounced in the
ADHD1ODD group than in the ADHD-only group but would be
present in both, given that previous studies have implicated
the frontal lobe in both ADHD and ODD.
METHODS AND MATERIALS
Participants
Participants were selected from the NeuroIMAGE cohort [for a
full description, see the Supplement and (23)]. Inclusion criteria
for the current study were as follows: European Caucasian
descent, IQ $ 80 (as estimated with the vocabulary and block
design subtests of an age-appropriate Wechsler Intelligence
Scale for Children or Wechsler Adult Intelligence Scale),
and no diagnosis of autism/Asperger’s/anxiety disorder/
depression/epilepsy/general learning difﬁculties/brain disor-
ders/known genetic disorders (e.g., fragile X syndrome or
Down syndrome). Control subjects were not allowed to have a
previous or current diagnosis of ADHD, ODD, or any other
psychiatric disorder. A total of 1069 participants contributed
data to NeuroIMAGE: 751 participants from ADHD families
(participants in the ADHD-only or ADHD1ODD group and their
biological siblings) and 318 participants from control families
[participants in the TDC group and their biological siblings
(23)]. For the current study, only individuals with a current
ADHD diagnosis, with comorbid ODD (n = 67) and without
comorbid ODD (n = 243), and TDC subjects (n = 233) were
included. Not all participants in the NeuroIMAGE study un-
derwent a magnetic resonance imaging (MRI) scanning ses-
sion because of contraindications for MRI.
Diagnostic Assessment
A full description of the diagnostic assessment has been
provided in previous work [Supplement and (24)]. In short,
participants were diagnosed with ADHD or ODD according
to DSM-IV criteria. Individuals in the ADHD1ODD group
qualiﬁed for a diagnosis of both ADHD and ODD, while in-
dividuals in the ADHD-only group only qualiﬁed for a diag-
nosis of ADHD. A diagnostic algorithm was applied to create
a combined symptom count from the questionnaires and
interview.
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MRI Acquisition and Analysis
MRI data were acquired on a 1.5T Siemens Sonata (Siemens,
Erlangen, Germany) scanner (used at the Amsterdam scanning
site) and on a Siemens Avanto scanner (used at the Nijmegen
scanning site). Both sites used a standard identical 8-channel
phased array coil and closely matched scan parameters
(Supplement).
Cortical reconstruction and volumetric segmentation
were performed with FreeSurfer software version 5.3 with
default settings (http://surfer.nmr.mgh.harvard.edu/) (see the
Supplement for the investigated areas and quality assurance
procedures). FreeSurfer is an image processing pipeline
including a volume-based route to subcortical segmentation
(25), and a surface-based route to create a three-dimensional
reconstruction and parcellation of the cortical sheet (26,27).
From FreeSurfer parcellations and segmentations (27) we
calculated total gray matter, total cortical matter, and cortical
and subcortical volumes, as well as bilateral volumes for each
brain region. In addition, FreeSurfer was used to calculate
cortical thickness measures. Regions were based on the
Desikan-Killiany atlas (27), and anoverviewof investigatedareas
can be found in the Supplement.
Procedure
The current study was part of a comprehensive assessment
protocol encompassing phenotypic, neurocognitive, and MRI
assessments (23) (details in the Supplement). Informed consent
was signed by all participants (for participants,12 years of age,
only parents signed informed consent; for participants 12–18
years of age, both the participants and their parents signed;
for participants .18 years of age, only the participants signed).
The study was approved by the local ethics committees.
Statistical Analyses
Groups were compared on demographic characteristics using
analysis of variance or c2 tests. All analyses that tested group
differences in neuroanatomical characteristics were performed
using the mixed models procedure in SPSS software (version
21.0; IBM Corp., Armonk, NY). Mixed model analyses were
performed with a random intercept, with an exchangeable
structure for family, to account for the hierarchical structure
due to family relations (siblings with ADHD in the diagnostics
group or siblings without ADHD in the control group) in the
data. Group differences were examined as a ﬁxed effect. To
correct for multiple testing, false discovery rate (FDR)–
corrected results were reported (maximum acceptable FDR
of 5%), based on the sequential Benjamini–Hochberg FDR
correction algorithm (28). When an overall signiﬁcant main
effect of group was found, post hoc pairwise group compari-
sons (least signiﬁcant difference) were assessed.
Linear interaction effects between group and possible
moderator variables (age [linear/nonlinear], gender, IQ, medi-
cation use, and scan site) were assessed. When a signiﬁcant
interaction effect was present, the main effect of the moderator
and interaction effect between group and moderator were
added to the model. In that case, interactions were plotted to
clarify the direction of the interaction. When the interaction
term was not signiﬁcant, but only a main effect was found, the
variable was included in the model as a covariate.
RESULTS
A total of 542 participants took part in this study: 67 partici-
pants with ADHD1ODD, 243 participants with ADHD-only, and
233 TDC subjects. The mean age was 16 years (SD 3.5 years
[range 7–29 years]), and individuals from the three groups
where similarly spread out across the age range. Table 1
shows additional group characteristics. The diagnostic
groups did not differ from the TDC group in age (p. .225, both
diagnostic groups) but did differ in IQ (p , .001, both diag-
nostic groups; higher IQ in the control group) and gender
(p , .001 for ADHD-only, p = .026 for ADHD1ODD; more
females in the control group). Furthermore, the diagnostic
groups showed higher levels of total ADHD, hyperactive and
inattentive symptoms, and ODD symptoms compared with the
control group (p , .001 for both diagnostic groups; fewer
symptoms in the control group). The ADHD1ODD and ADHD-
only groups did not differ from each other in IQ (p = .532) or
gender (p = .803). However, compared with the ADHD-only
group, the ADHD1ODD group showed a higher level of ODD
symptoms (p , .001) as well as a higher level of total (p ,
.001), hyperactive (p = .021), and inattentive (p , .001) ADHD
symptoms. Given these differences in ADHD symptom count
between diagnostic groups, sensitivity analyses were per-
formed for those regions for which group differences were
observed between the diagnostic groups. For these analyses,
total ADHD symptom count was entered as covariate.
We found no signiﬁcant interactions between group and
gender, IQ, medication use, or scan site. However, age (linear
only), gender, IQ, and scan site added signiﬁcantly to the
model for the majority of the structures. Therefore, these var-
iables were included as covariates in all models. For the
volumetric analyses, total intracranial volume was added as an
additional covariate. Results for the main group comparisons
are shown in Supplemental Table S1 (volume) and
Supplemental Table S2 (cortical thickness), including the post
hoc comparisons after FDR correction. Table 2 shows the
results of the sensitivity analyses (accounting for ADHD
symptom severity) for the diagnostic groups that survived FDR
correction.
Group Effects
Total Cortical, Gray Matter, and Subcortical Gray
Matter Volume. For total cortical volume (pFDR-corrected =
.001) and total gray matter volume (pFDR-corrected = .001), both
diagnostic groups showed reduced volumes compared with
the control group but did not differ from each other (p = .103
and p = .126, respectively). There were no group differences
for total subcortical gray matter volume.
Cortical Volumes. There were several main group effects
(Figures 1–3 and Supplemental Table S1). Post hoc analysis
showed areas for which one or both of the diagnostic groups
differed from controls and areas for which the diagnostic groups
alsodiffered fromeachother. Structures that showed volumetric
reductions in both diagnostic groups compared with the control
group included the lateral orbitofrontal (left pFDR-corrected ,
.001; rightpFDR-corrected, .001), isthmus (leftpFDR-corrected = .006;
right pFDR-corrected , .001), inferior parietal gyrus (left
pFDR-corrected , .001; right pFDR-corrected = .015), caudal middle
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frontal (left pFDR-corrected = .002; right pFDR-corrected = .002), right
parahippocampal gyrus (pFDR-corrected , .001), right medial
orbitofrontal gyrus (pFDR-corrected , .001), right superior frontal
gyrus (pFDR-corrected = .002), left precentral gyrus (pFDR-corrected =
.004), right rostral middle frontal gyrus (pFDR-corrected = .005), and
left lateral occipital gyrus (pFDR-corrected = .005).
Several of the structures showed a stepwise signiﬁcant
reduction in volume, with the largest volumetric reduction in
the ADHD1ODD group, followed by the ADHD-only group,
compared with the control group. These structures were the
lateral orbitofrontal, right medial orbitofrontal, right superior
frontal, right caudal middle frontal, and left inferior parietal
gyrus (Figure 1). Finally, there were ﬁve areas showing a
disorder-speciﬁc volumetric reduction compared with controls
(Figure 2). For the left rostral middle frontal (pFDR-corrected =
.002), left medial orbitofrontal (pFDR-corrected = .004), right
precuneus (pFDR-corrected = .005), and left pars triangularis
(pFDR-corrected = .007), the ADHD1ODD group showed a
Table 2. Results of Diagnostic Group Comparisons Accounting for ADHD Symptom Severity—Volume
Structure Lateralization
ADHD1ODD
(n = 67)
ADHD-Only
(n = 243)
Main Effect
of Group
Post Hoc Group
Comparisons
Linear Volumetric Reduction, mL
Lateral orbitofrontal Left 8.69 6 1.43 8.95 6 1.09 F1,301 = 5.24
a ADHD-only . ADHD1ODD
Right 8.45 6 1.51 8.72 6 1.06 F1,300 = 5.53
a ADHD-only . ADHD1ODD
Medial orbitofrontal Right 5.72 6 0.87 5.89 6 0.69 F1,297 = 6.63
a ADHD-only . ADHD1ODD
Caudal middle frontal Right 6.93 6 1.57 7.22 6 1.28 F1,295 = 3.38 NS
Inferior parietal gyrus Left 13.83 6 2.51 14.32 6 2.04 F1,299 = 6.19
a ADHD-only . ADHD1ODD
Superior frontal gyrus Right 25.58 6 3.63 26.08 6 3.11 F1,295 = 4.38
a ADHD-only . ADHD1ODD
Disorder Speciﬁcity, mL
Rostral middle frontal Left 18.89 6 3.14 19.32 6 2.80 F1,294 = 7.69
b ADHD-only . ADHD1ODD
Medial orbitofrontal Left 5.58 6 0.93 5.83 6 0.76 F1,301 = 7.04
b ADHD-only . ADHD1ODD
Precuneus Right 10.99 6 1.56 11.23 6 1.44 F1,286 = 4.57
a ADHD-only . ADHD1ODD
Pars triangularis Left 3.99 6 0.61 4.20 6 0.70 F1,300 = 6.46
a ADHD-only . ADHD1ODD
Middle temporal gyrus Left 12.32 6 1.97 12.68 6 1.84 F1,301 = 4.09
a ADHD-only . ADHD1ODD
Values presented as mean 6 SD.
ADHD, attention-deﬁcit/hyperactivity disorder; ODD, oppositional deﬁant disorder.
ap , .05.
bp , .01.
Table 1. Group Characteristics
Measure
ADHD1ODD
(n = 67)
ADHD-Only
(n = 243)
TDC
(n = 233) Group Comparisons
Age, Years (Range) 16.3 6 3.2 (8–22) 17.0 6 3.5 (7–25) 16.6 6 3.6 (7–29) NS
IQ 98.0 6 11.2 96.9 6 16.1 105.9 6 13.9 ADHD1ODD , TDC,a ADHD-only , TDC,a
ADHD1ODD = ADHD-only
Male Gender, % 66 68 55 ADHD1ODD . TDC,b ADHD-only . TDC,a
ADHD1ODD = ADHD-only
Scan Site (Amsterdam), % 42 42 64 ADHD1ODD , TDC,c ADHD-only , TDC,a
ADHD1ODD = ADHD-only
Medication Use,d mg 58,373 6 49,668 61,848 6 57,795 – NS
ADHD Total Symptomse 14.3 6 2.5 12.9 6 3.0 1.3 6 2.4 ADHD1ODD . ADHD-only,a ADHD1ODD . TDC,a
ADHD-only . TDCa
Hyperactive Symptomse 6.6 6 2.1 5.8 6 2.4 0.5 6 1.2 ADHD1ODD . ADHD-only,b ADHD1ODD . TDC,a
ADHD-only . TDCa
Inattentive Symptomse 7.8 6 1.2 7.1 6 1.8 0.8 6 1.6 ADHD1ODD . ADHD-only,a ADHD1ODD . TDC,a
ADHD-only . TDCa
ODD Symptomse 5.1 6 1.2 1.0 6 1.8 0.0 6 0.5 ADHD1ODD . ADHD-only,a ADHD1ODD . TDC,a
ADHD-only . TDCa
Values presented as percent or mean 6 SD (range).
ADHD, attention-deﬁcit/hyperactivity disorder; NS, not signiﬁcant; ODD, oppositional deﬁant disorder; TDC, typically developing control subject.
ap , .001.
bp , .05.
cp , .01.
dCumulative stimulation medication intake, calculated by multiplying treatment duration and mean daily dose, corrected for age (53).
eAs measured using the combination of Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime
version and Conners Scale total, inattentive, and hyperactive/impulsive symptoms.
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reduced volume compared with both the control group and the
ADHD-only group (that did not differ from each other; p = .311,
p = .566, p = .087, and p = .332, respectively). For
the left middle temporal gyrus (pFDR-corrected = .010), the
ADHD1ODD group showed a reduced volume compared with
the control group, but not compared with the ADHD-only
group (p = .050). The control and ADHD-only groups did not
differ (p = .104).
Results of post hoc exploratory whole-brain voxelwise
group comparisons showed no clusters surviving FDR-
corrected voxelwise multiple comparisons. Uncorrected (p ,
.0001) voxelwise results largely overlapped with the ﬁndings
using a region of interest approach (Figure 1 and Supplemental
Figures S1–S3).
Subcortical Volumes. There were no main group effects
for any of the subcortical structures.
Cortical Thickness. There were no main group effects for
cortical thickness of any of the structures (Supplemental
Table S2).
Effects of Group by Age. We found no signiﬁcant linear or
quadratic interactions between group and age for any of the
volumes or for cortical thickness surviving FDR correction.
Thus, the interactions were not included in the models.
Sensitivity Analysis Diagnostic Groups
For all 11 structures that showed differences between the
diagnostic groups (Table 2), the analyses were rerun for the
diagnostic groups while accounting for total number of ADHD
symptoms. For ﬁve of the six structures, the ﬁnding of step-
wise greater volumetric reductions in the ADHD1ODD group
compared with the ADHD-only group remained signiﬁcant
(right medial orbitofrontal pFDR-corrected = .011, left inferior
Figure 1. Overall volumetric group differences between the three groups,
based on whole brain voxelwise analyses. Lateral (top) and sagittal (bottom)
view of the left (left) and right (right) hemispheres. Colored areas indicate
clusters exhibiting overall group differences in cortical volume for all three
groups (control subjects, attention-deﬁcit/hyperactivity disorder only, and
attention-deﬁcit/hyperactivity disorder plus oppositional deﬁant disorder).
Results are uncorrected for multiple comparisons (p , .0001). Yellow in-
dicates the center of gravity for the clusters. Dark gray indicates sulci; light
gray indicates gyri.
Figure 2. Stepwise volumetric reductions. Volumes are provided in milliliters (mL), and the error bars represent 95% conﬁdence intervals. ADHD, attention-
deﬁcit/hyperactivity disorder; ODD, oppositional deﬁant disorder; TDC, typically developing control subjects. *p , .05, **p , .01, ***p , .001.
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parietal gyrus pFDR-corrected = .013, right lateral orbitofrontal
pFDR-corrected = .019, left lateral orbitofrontal pFDR-corrected =
.023, and right superior frontal pFDR-corrected = .037). Finally, for
all four structures, the ADHD1ODD–speciﬁc reduction
remained signiﬁcant (left rostral middle frontal pFDR-corrected =
.006, left medial orbitofrontal pFDR-corrected = .008, left pars
triangularis pFDR-corrected = .012, and right precuneus
pFDR-corrected = .033). The disorder-speciﬁc reduction in the left
middle temporal gyrus for the ADHD1ODD compared with the
control group, became also signiﬁcant between the
ADHD1ODD and ADHD-only group (p = .044).
DISCUSSION
We found several structures that showed volumetric abnor-
malities in the ADHD1ODD and/or ADHD-only group
compared with TDC subjects. Frontal regions showed the
hypothesized linear decrease in volume (ADHD1ODD ,
ADHD-only , controls). Unlike others (29), we found no later-
alization for the volumetric abnormalities. After accounting for
ADHD symptom severity, most of the linear volumetric
reductions and all disorder-speciﬁc volumetric reductions for
the ADHD1ODD group persisted. We found no cortical
thickness abnormalities. Finally, there were no interactions
between group and age for our outcome measures.
Our results show that abnormalities in frontal regions are
most strongly pronounced in the ADHD1ODD group
compared with the ADHD-only group, in line with our
hypothesis. For the left pars triangularis, left medial orbito-
frontal, and left rostral middle frontal gyri, ADHD1ODD
group-speciﬁc volumetric abnormalities were present. In
addition, for the lateral orbitofrontal, right medial orbitofrontal,
right caudal middle frontal, and right superior frontal gyrus, a
linear volumetric decrease was present, with the largest re-
ductions in the ADHD1ODD group, followed by the ADHD-
only group. Most group differences remained present after
controlling for ADHD symptom severity, suggesting that these
larger abnormalities are driven by both ADHD and ODD and
result in a “double burden.” This ﬁnding is in line with neu-
rocognitive ﬁndings of impairments in inhibitory control,
attention, decision making, and working memory, all functions
that are heavily dependent on integrity of the (superior) frontal
cortex, for both individuals with ADHD and individuals with
ODD, and the observation that these neurocognitive impair-
ments are worse in the comorbid group (3,10,30). Consistent
with these ﬁndings, we found a similar linear decrease in
volume of the left inferior parietal gyrus over the groups that
also remained present when controlling for ADHD severity.
Thus, in line with the literature showing a neurocognitive
double burden for individuals with ADHD1ODD, this group
also shows greater reductions in neuroanatomical volumes
than individuals with ADHD-only.
The results also showed structural abnormalities in brain
regions for which we had no speciﬁc hypotheses. Similar
volumetric reductions in both diagnostic groups were present
for global measures of total gray matter and total cortical
volume. In addition, areas with similar volumetric reductions
included the isthmus of the cingulate gyrus, right para-
hippocampal gyrus, right inferior parietal gyrus, left lateral
occipital gyrus, and the left precentral gyrus. These ﬁndings
Figure 3. Disorder-speciﬁc volumetric reductions. Volumes are provided in milliliters (mL), and the error bars represent 95% conﬁdence intervals. ADHD,
attention-deﬁcit/hyperactivity disorder; ns, not speciﬁed; ODD, oppositional deﬁant disorder; TDC, typically developing control subjects. *p , .05, **p , .01,
***p , .001.
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are in line with previous studies showing widespread structural
abnormalities in ADHD with and without comorbid ODD
(2,3,20). These areas, among others, are associated with
neurocognitive impairments frequently observed in individuals
with ADHD and ODD, such as social learning, spatial
working memory, reward processing, and motor functioning
(3,10,30–32).
Disorder-speciﬁc abnormalities for the ADHD1ODD group
were observed in the right precuneus, one of the structures
that are associated with self-reﬂection processing, awareness,
and feelings of guilt (33,34), and the left middle temporal gyrus,
one of the structures that are associated with empathic pro-
cessing (33). Abnormalities of the precuneus have been related
to ODD/CD in a recent meta-analysis (21) and are in line with
both observed neurocognitive impairments associated with
ODD and with theoretical models on ODD that suggest that
impairments in social skills, such as the failure to exhibit
socially relevant behaviors and lack of guilt, are key features of
the disorder (34–36). The left middle temporal gyrus, among
other structures, is involved in empathic processing and has
been linked to antisocial personality disorder and psychopa-
thy, disorders that are related to ODD and show similar
behavioral problems in terms of a lack of adequate empathic
responses (10,37).
There was no evidence that volumetric abnormalities in the
basal ganglia or cerebellum were speciﬁc for ADHD, which was
not as hypothesized, because these were not present. Like-
wise, we found no evidence for cortical thickness abnormal-
ities in either of the diagnostic groups, in contrast with previous
studies (18). The absence of these abnormalities may be
related to the mean age of our sample (16 years), which is
relatively old compared with other studies (38). Especially for
cortical thickness, the abnormalities seem to normalize with
age (39,40). For the basal ganglia speciﬁcally, our sample with
ADHD may have outgrown their deﬁcits, as suggested in an
extensive review that reported that adults with ADHD no longer
show those abnormalities (2,41).
Our second hypothesis—that abnormalities in the amyg-
dala and the insula would be driven by ODD rather than by
ADHD—was not conﬁrmed. One possible explanation is that
previously reported abnormalities in amygdala and insula in
ADHD1ODD groups are driven by the presence of comorbid
CD, a comorbid condition that was absent in our sample.
This suggestion is supported by the fact that in previous
studies that showed an association between abnormalities
in the amygdala and the insula and ODD/CD, only mixed
samples of individuals with ODD and/or CD, rather than
individuals with ODD-only, were assessed (15,42). Thus,
since ODD has frequently been reported as a milder form of
CD and possibly acts as a precursor for CD, it may be
possible that these striatal structures may not be affected in
ODD (43).
We found no support for the maturational delay hypothesis
in terms of volume or cortical thickness. Although our sample
was on average relatively old compared to earlier studies on
brain development in ADHD, the age range was large enough
to be able to detect possible developmental differences. Since
the maturational delay seems most prominent in late childhood
(7–13 years of age) and our sample ranged up to 29 years, a
small effect of age may have been missed. Therefore, we
reanalyzed our data in an age-restricted subsample (7–13
years of age), with similar results (data not shown). It must
be acknowledged that the cross-sectional design of our study
limits the interpretability of the developmental results, and a
longitudinal design would be required to speciﬁcally test the
maturational delay hypothesis. Nevertheless, our ﬁndings are
based on a large, well-deﬁned sample following strict inclusion
criteria and are in line with a recent longitudinal study including
a large sample of children with ADHD (44). This suggests that
maybe the maturational delay hypothesis holds true for a
speciﬁc subset of individuals with ADHD, but not all.
Our study has some important strengths, such as the large
sample and well-deﬁned groups, but there are also some
limitations. First, it would have been valuable to also have an
ODD-only group to investigate whether the stronger abnor-
malities in the comorbid group are indeed related to ODD or
rather to an interaction between ADHD and ODD. Second,
even though we statistically controlled for effects of age,
gender, and IQ, this is not the same as investigating matched
groups. It is therefore possible that we missed small effects of
subtle neuroanatomical abnormalities. Third, most previous
studies in ADHD used voxel-based morphometry approaches,
while the current study used a surface-based morphometry
approach. This was preferred because surface-based
morphometry has been shown to be most robust across
different scanners (45). Although surface-based morphometry
and voxel-based morphometry are different approaches,
results in terms of cortical volume from both approaches are
highly correlated (46). Furthermore, our voxelwise results were
nonsigniﬁcant. Although the approaches differ substantially,
both have their merits and they may be seen as complemen-
tary (47). In addition, our ﬁndings did largely overlap with the
uncorrected voxelwise results, indicating that abnormalities
were distributed rather than focal. Fourth, the prevalence of
comorbid ODD in our sample is relatively low (22%) compared
to other studies, but is in line with the idea that comorbid
problems in ADHD emerge early in childhood and remit during
adolescence (48), and is a consequence of the strict inclusion
criteria applied (e.g., no mood/anxiety disorders, no CD).
However, ODD severity was still comparable with other studies
(mean 5.2 [range 4–8] symptoms).
Taken together, our study showed that both individuals with
ADHD-only and ADHD1ODD show volumetric reductions in
total gray matter and in brain areas crucial for attention,
(working) memory, and decision making, but do not show
abnormalities in similar brain areas in cortical thickness. Given
the absence of cortical thickness abnormalities, the observed
volumetric reductions are most likely driven by reduced sur-
face area development of the involved structures (49). Post
hoc analyses conﬁrmed reduced surface area for the diag-
nostic groups for the majority (79%) of structures for which
volumetric reductions were observed (Supplemental
Figure S3). This is in line with a study that showed regional
variation in the contribution of thickness and surface area to
volumetric differences (50). For the other areas, it may be that
small abnormalities in cortical thickness and surface area
together resulted in the observed volumetric reductions, but
this remains speculative. In addition, the volumetric reductions
in the frontal lobes were largest in the ADHD1ODD group,
possibly underlying the larger impairments in neurocognitive
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functions commonly observed in this comorbid group
(24,51,52). Thus, individuals with ADHD1ODD seem to face a
double burden and show an accumulation of the deﬁcits
associated with each of the separate disorders. Moreover,
there were disorder-speciﬁc abnormalities for the ADHD1ODD
group not only in the frontal regions, but also in the precuneus
and the middle temporal gyrus, in line with neurocognitive
ﬁndings of impairments in social skills in individuals with (co-
morbid) ODD.
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